As of 2025-12-22, the EV/EBITDA ratio of Tandem Diabetes Care Inc (TNDM) is -24.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TNDM's latest enterprise value is 1,718.89 mil USD. TNDM's TTM EBITDA according to its financial statements is -69.58 mil USD. Dividing these 2 quantities gives us the above TNDM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 13.4x | 11.1x |
| Forward P/E multiples | 13.3x - 19.8x | 16.4x |
| Fair Price | (16.95) - (17.06) | (17.42) |
| Upside | -176.8% - -177.3% | -178.9% |
| Date | EV/EBITDA |
| 2025-12-19 | -24.70 |
| 2025-12-18 | -24.44 |
| 2025-12-17 | -25.04 |
| 2025-12-16 | -25.22 |
| 2025-12-15 | -24.74 |
| 2025-12-12 | -24.04 |
| 2025-12-11 | -23.63 |
| 2025-12-10 | -24.10 |
| 2025-12-09 | -23.11 |
| 2025-12-08 | -23.41 |
| 2025-12-05 | -23.58 |
| 2025-12-04 | -23.38 |
| 2025-12-03 | -22.62 |
| 2025-12-02 | -22.32 |
| 2025-12-01 | -23.18 |
| 2025-11-28 | -23.67 |
| 2025-11-26 | -23.40 |
| 2025-11-25 | -24.48 |
| 2025-11-24 | -24.12 |
| 2025-11-21 | -23.93 |
| 2025-11-20 | -22.20 |
| 2025-11-19 | -21.46 |
| 2025-11-18 | -21.43 |
| 2025-11-17 | -21.07 |
| 2025-11-14 | -21.33 |
| 2025-11-13 | -20.28 |
| 2025-11-12 | -20.80 |
| 2025-11-11 | -20.27 |
| 2025-11-10 | -19.15 |
| 2025-11-07 | -19.04 |
| 2025-11-06 | -16.19 |
| 2025-11-05 | -17.49 |
| 2025-11-04 | -18.02 |
| 2025-11-03 | -17.19 |
| 2025-10-31 | -16.84 |
| 2025-10-30 | -17.41 |
| 2025-10-29 | -17.96 |
| 2025-10-28 | -17.91 |
| 2025-10-27 | -17.76 |
| 2025-10-24 | -17.77 |
| 2025-10-23 | -17.48 |
| 2025-10-22 | -17.78 |
| 2025-10-21 | -18.19 |
| 2025-10-20 | -18.34 |
| 2025-10-17 | -17.61 |
| 2025-10-16 | -18.10 |
| 2025-10-15 | -17.57 |
| 2025-10-14 | -17.21 |
| 2025-10-13 | -16.71 |
| 2025-10-10 | -16.84 |